334 related articles for article (PubMed ID: 32979782)
1. Pharmacologic treatment of orthostatic hypotension.
Park JW; Okamoto LE; Shibao CA; Biaggioni I
Auton Neurosci; 2020 Dec; 229():102721. PubMed ID: 32979782
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.
Ramirez CE; Okamoto LE; Arnold AC; Gamboa A; Diedrich A; Choi L; Raj SR; Robertson D; Biaggioni I; Shibao CA
Hypertension; 2014 Dec; 64(6):1235-40. PubMed ID: 25185131
[TBL] [Abstract][Full Text] [Related]
3. [Orthostatic hypotension and supine hypertension in primary autonomic failure. Pathophysiology, diagnosis and treatment].
Tykocki T; Guzek K; Nauman P
Kardiol Pol; 2010 Sep; 68(9):1057-63. PubMed ID: 20859904
[TBL] [Abstract][Full Text] [Related]
4. Association between supine hypertension and orthostatic hypotension in autonomic failure.
Goldstein DS; Pechnik S; Holmes C; Eldadah B; Sharabi Y
Hypertension; 2003 Aug; 42(2):136-42. PubMed ID: 12835329
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety of droxidopa in patients with symptomatic neurogenic orthostatic hypotension.
Isaacson S; Vernino S; Ziemann A; Rowse GJ; Kalu U; White WB
J Am Soc Hypertens; 2016 Oct; 10(10):755-762. PubMed ID: 27614923
[TBL] [Abstract][Full Text] [Related]
6. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.
Kaufmann H; Freeman R; Biaggioni I; Low P; Pedder S; Hewitt LA; Mauney J; Feirtag M; Mathias CJ;
Neurology; 2014 Jul; 83(4):328-35. PubMed ID: 24944260
[TBL] [Abstract][Full Text] [Related]
7. Diagnosing and treating neurogenic orthostatic hypotension in primary care.
Kuritzky L; Espay AJ; Gelblum J; Payne R; Dietrich E
Postgrad Med; 2015; 127(7):702-15. PubMed ID: 26012731
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of autonomic failure.
Shibao C; Okamoto L; Biaggioni I
Pharmacol Ther; 2012 Jun; 134(3):279-86. PubMed ID: 21664375
[TBL] [Abstract][Full Text] [Related]
9. Temporary elimination of orthostatic hypotension by norepinephrine infusion.
Goldstein DS; Sewell L; Holmes C; Pechnik S; Diedrich A; Robertson D
Clin Auton Res; 2012 Dec; 22(6):303-6. PubMed ID: 22983778
[TBL] [Abstract][Full Text] [Related]
10. Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.
Idiaquez JF; Idiaquez J; Casar JC; Biaggioni I
Am J Hypertens; 2021 Mar; 34(2):125-133. PubMed ID: 33705537
[TBL] [Abstract][Full Text] [Related]
11. Cardiac ectopy in chronic autonomic failure.
Goldstein DS
Clin Auton Res; 2010 Apr; 20(2):85-92. PubMed ID: 20012145
[TBL] [Abstract][Full Text] [Related]
12. L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure.
Mathias CJ; Senard JM; Braune S; Watson L; Aragishi A; Keeling JE; Taylor MD
Clin Auton Res; 2001 Aug; 11(4):235-42. PubMed ID: 11710796
[TBL] [Abstract][Full Text] [Related]
13. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension.
Donadio V; Incensi A; Rizzo G; De Micco R; Tessitore A; Devigili G; Del Sorbo F; Bonvegna S; Infante R; Magnani M; Zenesini C; Vignatelli L; Cilia R; Eleopra R; Tedeschi G; Liguori R
Mov Disord; 2020 Sep; 35(9):1649-1657. PubMed ID: 32557839
[TBL] [Abstract][Full Text] [Related]
14. Orthostatic Hypotension in Parkinson Disease.
Palma JA; Kaufmann H
Clin Geriatr Med; 2020 Feb; 36(1):53-67. PubMed ID: 31733702
[TBL] [Abstract][Full Text] [Related]
15. Neurogenic orthostatic hypotension in Parkinson's disease: evaluation, management, and emerging role of droxidopa.
Isaacson SH; Skettini J
Vasc Health Risk Manag; 2014; 10():169-76. PubMed ID: 24729712
[TBL] [Abstract][Full Text] [Related]
16. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
Senard JM; Brefel-Courbon C; Rascol O; Montastruc JL
Drugs Aging; 2001; 18(7):495-505. PubMed ID: 11482743
[TBL] [Abstract][Full Text] [Related]
17. Supine plasma NE predicts the pressor response to droxidopa in neurogenic orthostatic hypotension.
Palma JA; Norcliffe-Kaufmann L; Martinez J; Kaufmann H
Neurology; 2018 Oct; 91(16):e1539-e1544. PubMed ID: 30232253
[TBL] [Abstract][Full Text] [Related]
18. Neurogenic orthostatic hypotension: roles of norepinephrine deficiency in its causes, its treatment, and future research directions.
Loavenbruck A; Sandroni P
Curr Med Res Opin; 2015 Nov; 31(11):2095-104. PubMed ID: 26373628
[TBL] [Abstract][Full Text] [Related]
19. Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease.
Claassen D; Lew M
Clin Auton Res; 2017 Jul; 27(Suppl 1):13-14. PubMed ID: 28631224
[No Abstract] [Full Text] [Related]
20. Chemical pharmacotherapy for the treatment of orthostatic hypotension.
Cheshire WP
Expert Opin Pharmacother; 2019 Feb; 20(2):187-199. PubMed ID: 30376728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
